N4-(Cyclopropylmethyl)-N2-methyl-6-(pyridin-2-yl)pyrimidine-2,4-diamine

ID: ALA3342359

PubChem CID: 118716402

Max Phase: Preclinical

Molecular Formula: C14H17N5

Molecular Weight: 255.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNc1nc(NCC2CC2)cc(-c2ccccn2)n1

Standard InChI:  InChI=1S/C14H17N5/c1-15-14-18-12(11-4-2-3-7-16-11)8-13(19-14)17-9-10-5-6-10/h2-4,7-8,10H,5-6,9H2,1H3,(H2,15,17,18,19)

Standard InChI Key:  XYYAWWCGBSMEAW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
    3.0073   -2.7693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0062   -3.5889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7142   -3.9978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4239   -3.5884    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4211   -2.7657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7124   -2.3605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7159   -4.8129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0065   -5.2207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0059   -6.0371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7141   -6.4467    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4242   -6.0339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4213   -5.2188    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1333   -6.4401    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8396   -6.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2979   -6.4452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5905   -6.0361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8825   -6.4442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0691   -6.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4771   -7.1533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
 11 13  1  0
 13 14  1  0
  9 15  1  0
 15 16  1  0
 16 17  1  0
 18 17  1  0
 19 18  1  0
 17 19  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3342359

    ---

Associated Targets(Human)

GPR39 Tchem G-protein coupled receptor 39 (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpr39 G-protein coupled receptor 39 (34 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 255.32Molecular Weight (Monoisotopic): 255.1484AlogP: 2.40#Rotatable Bonds: 5
Polar Surface Area: 62.73Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.46CX LogP: 2.25CX LogD: 2.25
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.86Np Likeness Score: -1.25

References

1. Peukert S, Hughes R, Nunez J, He G, Yan Z, Jain R, Llamas L, Luchansky S, Carlson A, Liang G, Kunjathoor V, Pietropaolo M, Shapiro J, Castellana A, Wu X, Bose A..  (2014)  Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.,  (10): [PMID:25313322] [10.1021/ml500240d]

Source